OBJECTIVE: Determine the degree of congruence between several measures of adverse events. DESIGN: Cross-sectional study to assess frequency and type of adverse events identified using a variety of methods. SETTING: Mayo Clinic Rochester hospitals. PARTICIPANTS: All inpatients discharged in 2005 (n = 60 599). INTERVENTIONS: Adverse events were identified through multiple methods: (i) Agency for Healthcare Research and Quality-defined patient safety indicators (PSIs) using ICD-9 diagnosis codes from administrative discharge abstracts, (ii) provider-reported events, and (iii) Institute for Healthcare Improvement Global Trigger Tool with physician confirmation. PSIs were adjusted to exclude patient conditions present at admission. MAIN OUTCOME MEASURE: Agreement of identification between methods. RESULTS: About 4% (2401) of hospital discharges had an adverse event identified by at least one method. Around 38% (922) of identified events were provider-reported events. Nearly 43% of provider-reported adverse events were skin integrity events, 23% medication events, 21% falls, 1.8% equipment events and 37% miscellaneous events. Patients with adverse events identified by one method were not usually identified using another method. Only 97 (6.2%) of hospitalizations with a PSI also had a provider-reported event and only 10.5% of provider-reported events had a PSI. CONCLUSIONS: Different detection methods identified different adverse events. Findings are consistent with studies that recommend combining approaches to measure patient safety for internal quality improvement. Potential reported adverse event inconsistencies, low association with documented harm and reporting differences across organizations, however, raise concerns about using these patient safety measures for public reporting and organizational performance comparison.
OBJECTIVE: Determine the degree of congruence between several measures of adverse events. DESIGN: Cross-sectional study to assess frequency and type of adverse events identified using a variety of methods. SETTING:Mayo Clinic Rochester hospitals. PARTICIPANTS: All inpatients discharged in 2005 (n = 60 599). INTERVENTIONS: Adverse events were identified through multiple methods: (i) Agency for Healthcare Research and Quality-defined patient safety indicators (PSIs) using ICD-9 diagnosis codes from administrative discharge abstracts, (ii) provider-reported events, and (iii) Institute for Healthcare Improvement Global Trigger Tool with physician confirmation. PSIs were adjusted to exclude patient conditions present at admission. MAIN OUTCOME MEASURE: Agreement of identification between methods. RESULTS: About 4% (2401) of hospital discharges had an adverse event identified by at least one method. Around 38% (922) of identified events were provider-reported events. Nearly 43% of provider-reported adverse events were skin integrity events, 23% medication events, 21% falls, 1.8% equipment events and 37% miscellaneous events. Patients with adverse events identified by one method were not usually identified using another method. Only 97 (6.2%) of hospitalizations with a PSI also had a provider-reported event and only 10.5% of provider-reported events had a PSI. CONCLUSIONS: Different detection methods identified different adverse events. Findings are consistent with studies that recommend combining approaches to measure patient safety for internal quality improvement. Potential reported adverse event inconsistencies, low association with documented harm and reporting differences across organizations, however, raise concerns about using these patient safety measures for public reporting and organizational performance comparison.
Authors: Lindsay D Croft; Michael Liquori; James Ladd; Hannah Day; Lisa Pineles; Elizabeth Lamos; Ryan Arnold; Preeti Mehrotra; Jeffrey C Fink; Patricia Langenberg; Linda Simoni-Wastila; Eli Perencevich; Anthony D Harris; Daniel J Morgan Journal: Infect Control Hosp Epidemiol Date: 2015-08-17 Impact factor: 3.254
Authors: Hillary J Mull; Ann M Borzecki; Susan Loveland; Kathleen Hickson; Qi Chen; Sally MacDonald; Marlena H Shin; Marisa Cevasco; Kamal M F Itani; Amy K Rosen Journal: Am J Surg Date: 2013-11-07 Impact factor: 2.565
Authors: E S Kirkendall; W L Spires; T A Mottes; J K Schaffzin; C Barclay; S L Goldstein Journal: Appl Clin Inform Date: 2014-04-02 Impact factor: 2.342
Authors: Susann Muehlhans; Max von Kleist; Tatiana Gretchukha; Martin Terhardt; Ulrich Fegeler; Wolfgang Maurer; Leila Namazova-Baranova; Gerhard Gaedicke; Alexander Baranov; Barbara Rath Journal: Paediatr Drugs Date: 2014-08 Impact factor: 3.022
Authors: Jonathan D Burlison; Robert B McDaniel; Donald K Baker; Murad Hasan; Jennifer J Robertson; Scott C Howard; James M Hoffman Journal: Appl Clin Inform Date: 2018-01-31 Impact factor: 2.342
Authors: Jeremy P Daniels; Kate Hunc; D Douglas Cochrane; Roxane Carr; Nicola T Shaw; Annemarie Taylor; Susan Heathcote; Rollin Brant; Joanne Lim; J Mark Ansermino Journal: CMAJ Date: 2011-11-21 Impact factor: 8.262
Authors: Sarah A Arias; Zi Zhang; Carla Hillerns; Ashley F Sullivan; Edwin D Boudreaux; Ivan Miller; Carlos A Camargo Journal: Suicide Life Threat Behav Date: 2014-03-03